logo

CURI

CuriosityStream·NASDAQ
--
--(--)
--
--(--)
9.04 / 10
Outperform

Fundamental assessment: 9.0/10 points to superior condition. Key positives include strong shareholder equity growth rate (-18.42% YTD but ranked high), healthy net cash flow ratio (0.3303), and solid gross margin (55.14%). Weaknesses are a low quick ratio (2.20%) and negative asset-to-market value (-0.5007), which cap the score despite otherwise excellent metrics.

Fundamental(9.04)SentimentTechnical

Analysis Checks(8/10)

Revenue-MV
Value-1.02
Score3/3
Weight18.73%
1M Return4.43%
Inventory turnover ratio
Value47.85
Score2/3
Weight-5.49%
1M Return-1.44%
Gross profit margin (%)
Value55.14
Score3/3
Weight12.47%
1M Return3.09%
Profit-MV
Value0.46
Score3/3
Weight26.47%
1M Return6.42%
Quick ratio
Value2.20
Score1/3
Weight-9.56%
1M Return-2.61%
PB-ROE
Value3.04
Score3/3
Weight23.69%
1M Return6.16%
Shareholders’ equity attributable to parent company (growth rate compared to beginning of year %)
Value-18.42
Score3/3
Weight12.82%
1M Return3.04%
Net cash flow from operating activities / Total liabilities (%)
Value0.33
Score2/3
Weight0.54%
1M Return0.13%
Asset-MV
Value-0.50
Score0/3
Weight-11.62%
1M Return-3.72%
Cash-MV
Value-1.02
Score3/3
Weight31.96%
1M Return7.75%
Is CURI undervalued or overvalued?
  • CURI scores 9.04/10 on fundamentals and holds a Discounted valuation at present. Backed by its -5.03% ROE, -8.19% net margin, -40.32 P/E ratio, 4.08 P/B ratio, and 64.29% earnings growth, these metrics solidify its Outperform investment rating.